Chaire, V.
11  Ergebnisse:
Personensuche X
?
 
?
2

GSK3-beta as a candidate therapeutic target in soft tissue ..:

Verbeke, S. ; Perret, R. ; Chaire, V....
Journal of Hematology & Oncology.  14 (2021)  1 - p. , 2021
 
?
 
?
4

GSK3-beta as a candidate therapeutic target in soft tissue ..:

Verbeke, S ; Perret, R ; Chaire, V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641200/.  , 2021
 
?
5

BRCA1 haplotype and clinical benefit of trabectedin in soft..:

Laroche-Clary, A ; Chaire, V ; Le Morvan, V...
info:eu-repo/semantics/altIdentifier/doi/10.1038/bjc.2014.624.  , 2015
 
?
6

BRCA1 haplotype and clinical benefit of trabectedin in soft..:

Laroche-Clary, A ; Chaire, V ; Le Morvan, V...
info:eu-repo/semantics/altIdentifier/doi/10.1038/bjc.2014.624.  , 2015
 
?
7

BRCA1 haplotype and clinical benefit of trabectedin in soft..:

Laroche-Clary, A ; Chaire, V ; Le Morvan, V...
info:eu-repo/semantics/altIdentifier/doi/10.1038/bjc.2014.624.  , 2015
 
?
 
?
 
?
11

Additional file 1 of GSK3-beta as a candidate therapeutic t..:

S. Verbeke (11787671) ; R. Perret (11787674) ; V. Chaire (11787677)...
https://figshare.com/articles/journal_contribution/Additional_file_1_of_GSK3-beta_as_a_candidate_therapeutic_target_in_soft_tissue_sarcomas/17120012.  , 2021
 
1-11